High Note Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
High Note Wealth's REGN Position: Q2 2026 in Review
High Note Wealth reduced its Regeneron Pharmaceuticals (REGN) stake by 19% in Q2 2026, selling an estimated $2.72K and leaving 17 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #393.
High Note Wealth first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.2K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- High Note Wealth held 17 shares of Regeneron Pharmaceuticals worth $10.6K as of Q2 2026.
- High Note Wealth sold 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
- Regeneron Pharmaceuticals made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #393 holding.
- High Note Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- High Note Wealth's Regeneron Pharmaceuticals position peaked at $16.2K in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.